Atossa Therapeutics Inc.
Atossa Therapeutics Inc. (ATOS) — Form 10-Q: Quarterly report
About this filing
Atossa Therapeutics Inc. (ATOS) filed Form 10-Q (quarterly report) with the SEC on Aug 7, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More ATOS filings
- 8-K
Filed Nov 10, 2026
- 10-Q
Filed Nov 10, 2026
- 8-K
Filed Oct 9, 2026
- 8-K
Filed Sep 29, 2026
- 8-K
Filed Sep 18, 2026
- 8-K
Filed Aug 7, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.